Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2025 | $28.93 M | -59.75% |
2024 | $71.88 M | 27.44% |
2023 | $56.4 M | -14.65% |
2022 | $66.08 M | 7.92% |
2021 | $61.24 M | -56.04% |
2020 | $0.13 B | 67.82% |
2019 | $83.01 M | -43.79% |
2018 | $0.14 B | 69.32% |
2017 | $87.22 M | -29.4% |
2016 | $0.12 B | -16.47% |
2015 | $0.14 B | -18.15% |
2014 | $0.18 B | 579.65% |
2013 | $26.59 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Amgen AMGN | $82.72 M | $0.33 B | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $0.16 B | $0.25 B | ๐บ๐ธ USA |
![]() AbbVie ABBV | $33.49 M | $0.23 B | ๐บ๐ธ USA |
![]() Pfizer PFE | $28.79 M | $0.35 B | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $8.74 M | $0.19 B | ๐บ๐ธ USA |
![]() Acorda Therapeutics
ACOR | N/A | $0.01 M | ๐บ๐ธ USA |
![]() Sanofi SNY | $28.15 M | $43.66 M | ๐ซ๐ท France |
![]() Bio-Rad Laboratories BIO | $3.09 M | $17.23 M | ๐บ๐ธ USA |
![]() Illumina ILMN | $3.85 M | $72.94 M | ๐บ๐ธ USA |
![]() Qiagen QGEN | $2.71 M | $4.94 M | ๐ณ๐ฑ Netherlands |